Data from another study with a four-marker panel (CA125, apolipoprotein A-1, transthyretin, and transferrin) reported a sensitivity and specificity of 96% and 98%, respectively, for early-stage ovarian cancer [108]. Here, TTR is linked to ovarian cancer.